(Q52012322)

English

Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity.

scientific article published in June 2002

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

title

Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

author name string

Britta V Stern

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

Bernhard O Boehm

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

Magdalena Tary-Lehmann

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

language of work or name

English

0 references

publication date

1 June 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

published in

Journal of Immunology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

volume

168

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

page(s)

6099-6105

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

cites work

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1084/JEM.162.6.1745

Identifiers

DOI

10.4049/JIMMUNOL.168.12.6099

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

PubMed publication ID

12055220

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

ResearchGate publication ID

11319005

0 references

(Q52012322)

Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)